Related Experiment Videos
Unusual monoclonal DNA binding immunoglobulin.
The Tohoku Journal of Experimental Medicine
|March 1, 1983
Summary
Researchers developed DNA-binding monoclonal antibodies using hybridoma technology. These autoantibodies demonstrate potential for binding multiple DNA epitopes, including double-stranded DNA and DNA bases.
Area of Science:
- Immunology
- Molecular Biology
- Autoimmunity
Background:
- Autoimmune diseases are often characterized by the production of autoantibodies, including those targeting DNA.
- Understanding the specificity of these autoantibodies is crucial for diagnosing and potentially treating autoimmune conditions.
Purpose of the Study:
- To produce monoclonal antibodies specifically targeting DNA using hybridoma technology.
- To investigate the binding specificities and potential multi-antigen binding capabilities of these autoantibodies.
Main Methods:
- Somatic cell hybridization was employed, fusing parental cells (SP-2) with spleen cells from nonimmunized autoimmune MRL/lpr mice.
- Monoclonal immunoglobulins were isolated from hybridoma culture supernatants using solid immunoadsorbent and antibody immunoprecipitation techniques.
Main Results:
- The study successfully produced monoclonal antibodies that bind to DNA.
- Analysis of DNA-binding specificities revealed that these antibodies recognize both the double-stranded helix and base epitopes of DNA.
- The findings support the concept that hybridoma autoantibodies possess multiple antigen-binding potentials.
Conclusions:
- Monoclonal antibodies against DNA were effectively generated via hybridoma technology.
- These autoantibodies exhibit broad specificity, targeting diverse DNA structures.
- The results highlight the potential of hybridoma autoantibodies in understanding and targeting DNA-related autoimmune responses.